Cardiovascular outcomes by time-varying New York Heart Association class among patients with obstructive hypertrophic

Yan Wang1, Weihua Gao2, Xu Han2

  • 1Analysis Group, Inc, Los Angeles, CA, USA.

PubMed

Insights

Worsening New York Heart Association (NYHA) functional class in patients with obstructive hypertrophic cardiomyopathy (HCM) is linked to higher risks of death and cardiovascular events. Monitoring NYHA class is crucial for predicting adverse outcomes in HCM patients.

Area of Science:

  • Cardiology
  • Clinical Research
  • Patient Outcomes

Background:

  • Obstructive hypertrophic cardiomyopathy (HCM) is a significant cardiovascular condition.
  • The New York Heart Association (NYHA) functional class is a common metric for assessing disease severity.
  • Understanding the prognostic value of NYHA class in obstructive HCM is essential for patient management.

Purpose of the Study:

  • To evaluate the association between NYHA functional class and cardiovascular (CV) outcomes in patients with obstructive HCM.
  • To determine if changes in NYHA class over time impact CV event risk.

Main Methods:

  • Retrospective cohort study utilizing linked claims and electronic health records from the Optum Market Clarity database.
  • Included adults (≥18 years) with obstructive HCM and at least one NYHA class assessment.
  • Assessed thirteen CV outcomes using Kaplan-Meier method and cumulative incidence functions, with time-varying Cox models for risk evaluation.

Main Results:

  • The study included 4,631 patients with obstructive HCM.
  • Higher index NYHA class and worsening NYHA class over time were associated with increased risks of all-cause mortality and CV outcomes.
  • Deterioration in NYHA class correlated with elevated risks of adverse events.

Conclusions:

  • Worsening NYHA functional class is a significant predictor of increased all-cause mortality and cardiovascular events in obstructive HCM.
  • NYHA functional class serves as a valuable prognostic indicator in this patient population.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
14
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
15
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11